Skip to main
LTRN

Lantern Pharma (LTRN) Market Capitalization Overview

Market Cap: $39.04M as of Jan 9, 2026

$39.04M
$4.37M (10.05%)past month
As of Jan 9, 2026, Lantern Pharma (LTRN) has a market capitalization of $39.04M. Over the past 30 days, its market cap has decreased by -11.4%, while in the last 12 months, it has increased by 15.18%.

Market capitalization represents the total value of Lantern Pharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Lantern Pharma (LTRN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Lantern Pharma (LTRN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Lantern Pharma (LTRN) Market Cap History

DateMarket CapChange
Dec 1, 2025$39.26M-4.84%
Nov 3, 2025$41.26M-7.28%
Oct 1, 2025$44.50M+2.23%
Sep 2, 2025$43.53M-15.40%
Aug 1, 2025$51.45M+51.43%
Jul 1, 2025$33.98M-1.25%
Jun 2, 2025$34.41M-11.88%
May 1, 2025$39.05M+9.37%
Apr 1, 2025$35.70M-10.78%
Mar 3, 2025$40.02M-20.56%
Feb 3, 2025$50.37M+41.52%
Jan 2, 2025$35.59M+4.43%

Lantern Pharma (LTRN) End of Year Market Cap History

DateMarket CapChange
2026$39.04M+15.18%
2025$33.89M-1.50%
2024$34.41M-26.05%
2023$46.52M-29.06%
2022$65.58M-26.63%
2021$89.38M

FAQs About Lantern Pharma (LTRN) Market Cap

As of Jan 9, 2026, the market capitalization of Lantern Pharma (LTRN) is $39.04M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lantern Pharma’s market capitalization has decreased by -10.05%, changing from $43.40M to $39.04M as of Jan 9, 2026.

In the last 3 months, Lantern Pharma’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Lantern Pharma’s market capitalization decreased from $34.41M in January to $33.89M in December, reflecting a -1.5% change.

In the past five years, Lantern Pharma (LTRN) has had a compound annual growth rate (CAGR) of -17.63% in market capitalization. This means its market cap has shrunk at an average rate of -17.63% per year.

Lantern Pharma (LTRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.